Clinical Trial Update: Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing aflibercept in combination with radiation therapy and temozolomide in adults with newly diagnosed or recurrent glioblastoma, gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Gliosarcoma
• Malignant Glioma

Drugs mentioned

• Aflibercept (Aflibercept)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Status: COMPLETED